Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_012a67ad5254c14fa6a28e63b94be61f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13ae5141c0ab8440cb8834b5e6c552fb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6093 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-11 |
filingDate |
2010-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ae6fabe10a6391a4658842bdc32146a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db37d0749c42897b1a2440a2460da4d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d0ad6e54b78408f5d8251d7fa1cc7be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7617ae2e6683508a0392806785800189 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4510a8ba65f359ef2f8aa66c668faf00 |
publicationDate |
2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2010232180-B2 |
titleOfInvention |
Method for prophylaxis of influenza using vaccine for intranasal administration |
abstract |
The present invention provides a vaccine composition for transnasal mucous membrane administration, which contains an influenza virus antigen, polyriboinosinic polyribocytidylic acid (poly (I:C)) or a derivative thereof and a carboxyvinyl polymer. The present invention also provides a prophylactic method of influenza, including a step of administering the vaccine composition at least once to the nasal mucosa of a subject in need thereof. |
priorityDate |
2009-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |